Wiromrat Pattara, Jetsrisuparb Arunee, Komvilaisak Patcharee, Sirichativapee Winai, Kamsa-Ard Supot, Wiangnon Surapon
Department of Pediatrics, Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Asian Pac J Cancer Prev. 2012;13(9):4281-4. doi: 10.7314/apjcp.2012.13.9.4281.
Osteosarcoma is the most common bone cancer in children, responsible for a high rate of amputation and death. This is the first long-term, population-based, epidemiologic and survival study in Thailand.
To study the incidence and survival rates of pediatric osteosarcoma in Khon Kaen.
Childhood osteosarcoma cases (0-19 years) diagnosed between 1985-2010 were reviewed. The data were retrieved from the population-based data set of the Khon Kaen Cancer Registry and medical records from Srinagarind Hospital, Faculty of Medicine, Khon Kaen University. All cases were censored until the end of April 2012. The age-standardized incidence rate (ASR) was calculated using the standard method. Survival experience was analyzed using the standard survival function (STATA 9.0) and presented with a Kaplan-Meier curve.
58 cases were enrolled. The overall ASR was 14.1 per million. Males and females were equally affected. The peak incidence was for 15-19 year-olds in both sexes (ASR=10.4 per million in males and 8.5 in females). The 5-year overall survival rate was 27.6% (95% CI: 15.8-40.8%). The median survival time was 1.6 years (95% CI: 1.2-2.1). In a subgroup analysis, the patients who received only chemotherapy survived longer (5-year survival 45.7%, median survival time 4.1 years, p=0.12).
The incidence rate for childhood osteosarcoma was slightly less than those reported for Western countries. The survival rate was also lower than reports from developed countries. Further evaluation of the treatment protocol and risk factor stratification is needed.
骨肉瘤是儿童中最常见的骨癌,导致高截肢率和死亡率。这是泰国第一项基于人群的长期流行病学和生存研究。
研究孔敬小儿骨肉瘤的发病率和生存率。
回顾了1985年至2010年间诊断的儿童骨肉瘤病例(0至19岁)。数据取自孔敬癌症登记处的人群数据集以及孔敬大学医学院诗里拉吉医院的病历。所有病例均随访至2012年4月底。采用标准方法计算年龄标准化发病率(ASR)。使用标准生存函数(STATA 9.0)分析生存经验,并绘制Kaplan-Meier曲线。
共纳入58例病例。总体ASR为每百万14.1例。男性和女性受影响程度相同。两个性别的15至19岁人群发病率最高(男性ASR为每百万10.4例,女性为8.5例)。5年总生存率为27.6%(95%CI:15.8 - 40.8%)。中位生存时间为1.6年(95%CI:1.2 - 2.1)。在亚组分析中,仅接受化疗的患者存活时间更长(5年生存率45.7%,中位生存时间4.1年,p = 0.12)。
儿童骨肉瘤的发病率略低于西方国家报告的发病率。生存率也低于发达国家的报告。需要进一步评估治疗方案和危险因素分层。